Acasti Pharma (ACST) Shares Up 6.1%
Acasti Pharma Inc (NASDAQ:ACST)’s share price shot up 6.1% during mid-day trading on Wednesday . The company traded as high as $0.72 and last traded at $0.70. 596,568 shares were traded during mid-day trading, an increase of 3% from the average session volume of 578,111 shares. The stock had previously closed at $0.66.
Separately, ValuEngine upgraded shares of Acasti Pharma from a “hold” rating to a “buy” rating in a research report on Wednesday, October 17th.
The stock has a market cap of $52.58 million, a PE ratio of -0.92 and a beta of 1.57. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.56 and a current ratio of 0.56.
Acasti Pharma Inc, a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia.
Further Reading: How Do You Calculate Return on Investment (ROI)?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.